Hinge Health Inc. (NYSE:HNGE - Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $34.85, but opened at $36.40. Hinge Health shares last traded at $35.81, with a volume of 85,568 shares changing hands.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on HNGE shares. Morgan Stanley assumed coverage on shares of Hinge Health in a report on Monday. They set an "overweight" rating and a $46.00 target price on the stock. Royal Bank Of Canada started coverage on Hinge Health in a report on Monday. They set an "outperform" rating and a $45.00 price objective on the stock. Piper Sandler initiated coverage on shares of Hinge Health in a research note on Monday. They issued an "overweight" rating and a $41.00 price target for the company. Stifel Nicolaus assumed coverage on Hinge Health in a research note on Monday. They set a "buy" rating and a $48.00 price objective for the company. Finally, Evercore ISI began coverage on Hinge Health in a research note on Monday. They issued an "outperform" rating and a $50.00 target price on the stock. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $46.00.
Get Our Latest Stock Report on HNGE
Hinge Health Stock Performance
Hinge Health Company Profile
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Further Reading
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.